Literature DB >> 6130102

Ectopic growth hormone releasing factor stimulates growth hormone release from human somatotroph adenomas in vitro.

C B Webb, J L Thominet, L A Frohman.   

Abstract

The effects of an ectopic growth hormone releasing factor (E-GHRF) from a carcinoid tumor were studied in three human GH-secreting pituitary adenomas in monolayer culture. GH release by the adenomas was stimulated by 55 +/- 10%, 57 +/- 8%, and 59 +/- 17% during a 4 h exposure to E-GHRF at concentrations of 3, 0.8, and 24 Units/ml, respectively. Two of the tumors also secreted prolactin (PRL) and in one, E-GHRF (0.8 Units/ml) stimulated PRL release by 48 +/- 8%. GH and PRL release were both suppressed by somatostatin (10(-8)M) in two of the adenomas. These results 1) demonstrate for the first time E-GHRF stimulation of GH release from human pituitary tissue in vitro, 2) support an etiologic role for E-GHRF in the development of acromegaly, and 3) indicate that GH-secreting adenomas retain the capability of responding to GHRF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130102     DOI: 10.1210/jcem-56-2-417

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.

Authors:  I Shimon; J E Taylor; J Z Dong; R A Bitonte; S Kim; B Morgan; D H Coy; M D Culler; S Melmed
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Endocrinological differentiation of primary hypothalamic and pituitary disease.

Authors:  E E Müller
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

Review 3.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

4.  The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.

Authors:  M Giusti; A Lomeo; M Monachesi; G Mazzocchi; R Attanasio; P Sessarego; D Mignone; P Del Monte; G Giordano
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

5.  Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation.

Authors:  S Kawakita; S L Asa; K Kovacs
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

6.  Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy.

Authors:  A Grossman; N Lytras; M O Savage; J A Wass; D H Coy; L H Rees; A E Jones; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

7.  The effects of growth hormone-releasing factor (GRF) and dopamine on growth hormone (GH) secretion in acromegaly.

Authors:  M Giusti; A Lomeo; G Mazzocchi; D Mignone; P Sessarego; M Monachesi; G Giordano
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

8.  Hyperpolarization of the membrane potential caused by somatostatin in dissociated human pituitary adenoma cells that secrete growth hormone.

Authors:  N Yamashita; N Shibuya; E Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.